Will Celcuity's VIKTORIA-1 Hit The Target?
Shares of Celcuity Inc. (CELC) are down 34% from their 52-week high of $14.40, recorded in January of this year, to trade around $9..
Source: rttnews.com
📰 Planned Trials News
Planned Trials News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Planned Trials. Real-time updates on events, politics, business and more.
Will Celcuity's VIKTORIA-1 Hit The Target?
Shares of Celcuity Inc. (CELC) are down 34% from their 52-week high of $14.40, recorded in January of this year, to trade around $9..
Source: rttnews.com
Remember To Check Cognition Stock
Cognition Therapeutics Inc. (CGTX), a clinical-stage neuroscience company, has two key catalysts to watch in the coming months..
National Institute On Aging Cognition Therapeutics Inc Cognition Therapeutics Planned Trials National Institute Nasdaq Global Market
Source: rttnews.com
Global Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials an
DUBLIN--(BUSINESS WIRE)--The "Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the current and future competitive landscape in Waldenstrom Ma...
United States Waldenstrom Macroglobulinemia Laura Wood E St Office Hours Call Development Stage Office Hours Call
Source: pharmiweb.com